Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 12.37% |
| 4 | Industrials | 10.61% |
| 5 | Consumer Staples | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Luxfer Holdings
LXFR
$457M
| $1.92M | ﹤0.01% |
101,500
+15,300
| +18% | +$293K |
|
|
FLNA
1752
Filana Therapeutics
FLNA
$44.3M
| $1.92M | ﹤0.01% |
47,727
-9,628
| -17% | -$356K |
|
1753
Myriad Genetics
MYGN
$295M
| $1.92M | ﹤0.01% |
49,200
-13,600
| -22% | -$506K |
|
1754
Amtech Systems
ASYS
$280M
| $1.91M | ﹤0.01% |
156,496
-2,600
| -2% | -$25.8K |
|
|
TLRA
1755
DELISTED
Telaria, Inc.
TLRA
| $1.91M | ﹤0.01% |
+405,067
| New | +$1.73M |
|
1756
First Financial Bankshares
FFIN
$5.04B
| $1.91M | ﹤0.01% |
121,708
+8,800
| +8% | +$133K |
|
|
CACB
1757
DELISTED
Cascade Bancorp
CACB
| $1.89M | ﹤0.01% |
363,311
+323,916
| +822% | +$1.55M |
|
1758
First Bancorp
FBNC
$2.73B
| $1.89M | ﹤0.01% |
103,041
+46,641
| +83% | +$839K |
|
|
BGG
1759
DELISTED
Briggs & Stratton Corp.
BGG
| $1.89M | ﹤0.01% |
+92,300
| New | +$1.95M |
|
|
PRO
1760
DELISTED
PROS Holdings
PRO
| $1.89M | ﹤0.01% |
71,275
-37,925
| -35% | -$986K |
|
|
SBR
1761
Sabine Royalty Trust
SBR
$1.07B
| $1.89M | ﹤0.01% |
31,100
+4,911
| +19% | +$272K |
|
|
WTT
1762
DELISTED
Wireless Telecom Group, Inc.
WTT
| $1.88M | ﹤0.01% |
704,600
+11,300
| +2% | +$28.3K |
|
|
ICAD
1763
DELISTED
iCAD Inc
ICAD
| $1.87M | ﹤0.01% |
292,260
-59,200
| -17% | -$440K |
|
1764
China Automotive Systems
CAAS
$141M
| $1.87M | ﹤0.01% |
215,343
-3,858
| -2% | -$32K |
|
|
HIL
1765
DELISTED
Hill International, Inc. Common Stock
HIL
| $1.87M | ﹤0.01% |
299,800
+241,932
| +418% | +$1.54M |
|
|
MFLX
1766
DELISTED
MULTI-FINELINE ELECTRONIX INC
MFLX
| $1.86M | ﹤0.01% |
168,500
+25,400
| +18% | +$285K |
|
|
MDCI
1767
DELISTED
MEDICAL ACTION INDS INC
MDCI
| $1.86M | ﹤0.01% |
135,500
+60,700
| +81% | +$440K |
|
|
CRESY
1768
Cresud
CRESY
$749M
| $1.86M | ﹤0.01% |
161,850
+38,807
| +32% | +$401K |
|
1769
Immersion
IMMR
$248M
| $1.86M | ﹤0.01% |
145,913
-60,771
| -29% | -$659K |
|
1770
Pan American Silver
PAAS
$19.9B
| $1.84M | ﹤0.01% |
119,817
+104,087
| +662% | +$1.38M |
|
1771
Forestar Group
FOR
$1.5B
| $1.84M | ﹤0.01% |
96,300
+17,134
| +22% | +$304K |
|
1772
LifeVantage
LFVN
$81M
| $1.83M | ﹤0.01% |
182,014
+60,815
| +50% | +$577K |
|
|
ZNH
1773
DELISTED
China Southern Airlines Company Limited
ZNH
| $1.83M | ﹤0.01% |
122,189
+32,053
| +36% | +$489K |
|
|
NKA
1774
DELISTED
NISKA GAS STORAGE PARTNERS LLC UNIT LTD LIABILITY CO INTS
NKA
| $1.83M | ﹤0.01% |
119,000
+42,997
| +57% | +$643K |
|
1775
MaxLinear
MXL
$7.57B
| $1.83M | ﹤0.01% |
181,400
-31,800
| -15% | -$292K |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.